t

Product Categories

Abbott Diagnostics

Haematology Solutions

Abbott Diagnostics are not just about assays and instruments; their reach is much broader and global.

 

With a rich history of innovation and more than 700 scientists among their staff, Abbotts’ solutions span the world of laboratory operations, from processing tests to final results reporting. The long-term pipeline of advanced technologies is designed to provide our customers with even greater improvements in efficiency and accuracy.

Read More

Abbott offer a complete portfolio of haematology solutions, including automated analysersslide-maker stainers as well as reagents, calibrators and controls for laboratories with diverse testing volumes. In addition to haematology analysers and systems, Abbott’s total haematology solution encompasses dedicated customer service and personalised educational resources that are designed to improve your laboratory’s performance in today’s changing healthcare environment.

 

Contact us if you would like further information on Abbott Diagnostics Haematology Solutions or view more of our Clinical Diagnostics range.

BioMedica Diagnostics

Haemostasis and Thrombosis Diagnostic Products

BioMedica brings innovation, quality, and affordable diagnostic products in the fields of Haemostasis and Thrombosis.

Read More

BioMedica brings innovation, quality, and affordable diagnostic products in the fields of Haemostasis and Thrombosis.

 

Bleeding profiles are screening tests (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time, Fibrinogen, D-dimer) designed to detect abnormal blood clotting. Based on the pathways of the coagulation cascade, the test results when interpreted together are used to identify deficiencies and defects in coagulation factors, the presence of inhibitors to coagulation factors, the effectiveness of blood-thinning medications, hereditary conditions, severe infections and liver problems. The bleeding profile may also be performed to confirm normal blood clotting prior to a surgical procedure.

 

Contact us if you would like further information on BioMedica Diagnostics or view more of our Clinical Diagnostics range.

Cytomark

Cell Stabilisation Reagent

TransFix was developed in the 1990s by medical scientists from UK NEQAS, an arm of the National Health Service (NHS). In 2005 Dr Tim Almond launched Cytomark and secured the NHS licensed TransFix, making it readily available to clinical and scientific establishments world-wide.

Read More

TransFix was developed in the 1990s by medical scientists from UK NEQAS, an arm of the National Health Service (NHS). In 2005 Dr Tim Almond launched Cytomark and secured the NHS licensed TransFix, making it readily available to clinical and scientific establishments world-wide.

 

Transfix Bulk is intended for stabilising human whole blood specimens for immunophenotyping of white blood cells by flow cytometry. It is available as a CE/IVD and US GPR product, and can be purchased in 20ml or 1ml containers.

 

TransFix can also be used for a variety of specimen types including: cerebrospinal fluid, lymph nodes, bone marrow, animal blood, circulating tumour cells, cell free RNA and exosome isolation.

 

Contact us if you would like further information on Cytomark Cell Stabilisation Reagent or view more of our Clinical Diagnostics range.

Diagast

Blood Grouping Reagents

Receiving blood is receiving life. Diagast’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable.

Read More

Receiving blood is receiving life. Diagast’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable.

 

Over the last 30 years, Diagast has developed a unique expertise and know-how in the transfusion sector. These values allow the healthcare professionals to insure the total transfusional compatibility between receivers and donors. Thus Diagast has combined biology with information technology, to make its equipment evolving in parallel with the best of the new technology.

 

Contact us if you would like further information on Diagast Blood Grouping Reagents or view more of our Clinical Diagnostics range.

Eurotrol

Quality Control Materials

Eurotrol provides high specification, custom-made quality control materials (QC) for the periodic verification of the precision and accuracy of in vitro diagnostics (IVD) analysers. Their products are produced by an integrated ISO-approved process, from research and development through production, in which only the highest quality materials are used.

Read More

Eurotrol provides high specification, custom-made quality control materials (QC) for the periodic verification of the precision and accuracy of in vitro diagnostics (IVD) analysers. Their products are produced by an integrated ISO-approved process, from research and development through production, in which only the highest quality materials are used.

 

Eurotrol is a niche player in the world quality control market, offering a wide array of options. Their products have been tailored to meet the needs of the diagnostics industry (OEM), PT / EQA programs, standardisation bodies, hospital laboratories and point of care sites.

 

Contact us if you would like further information on Eurotrol or view more of our Clinical Diagnostics range.

Grifols

Transfusion Medicine

Grifols is a global healthcare company whose mission is to improve the health and well-being of people around the world. Grifols accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

Read More

Grifols is a global healthcare company whose mission is to improve the health and well-being of people around the world. Grifols accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

 

Grifols three primary divisions — Bioscience, Diagnostic and Hospital – which develop, produce and market their innovative products and services to medical professionals in more than 90 countries around the world.

 

As an experienced and trusted partner to blood banks and hospital transfusion centres, Grifols shares your commitment to transfusion safety. Their comprehensive transfusion medicine portfolio includes solutions for collectionscreeningtyping, and transfusion, all designed to help you work efficiently and deliver blood that is safer and compatible.

 

Contact us if you would like further information on Grifols Transfusion Medicine portfolio or view more of our Clinical Diagnostics or Life Sciences range.

Hart Biologicals

IVD Products

Hart Biologicals is engaged in the research, development, manufacture, and marketing of a range of “in-vitro” diagnostic products for use in the detection, prevention, and monitoring of a number of medical conditions related to haemostasis and platelet function. Hart Biologicals provide innovative and quality medical products to meet the needs of an ever-changing healthcare field.

Read More

Hart Biologicals is engaged in the research, development, manufacture, and marketing of a range of “in-vitro” diagnostic products for use in the detection, prevention, and monitoring of a number of medical conditions related to haemostasis and platelet function. Hart Biologicals provide innovative and quality medical products to meet the needs of an ever-changing healthcare field.

 

The first choice of reagent to monitor Warfarin therapy. Hart Biologicals also focus on all areas of Coagulation and Platelet Aggregation.

 

Contact us if you would like further information on Hart Biologicals or view more of our Clinical Diagnostics range.

Hemosure

Faecal Occult Blood (FOB) Testing

Hemosure is recognised worldwide in immunological faecal occult blood testing, also known as FOB or FIT testing. Colorectal Cancer, when discovered in the early stages, is the most preventable and curable of all cancers.

Read More

Hemosure is recognised worldwide in immunological faecal occult blood testing, also known as FOB or FIT testing. Colorectal Cancer, when discovered in the early stages, is the most preventable and curable of all cancers. Routine CRC screening is extremely important, which is why Hemosure is dedicated and focused on educating physicians and patients on this subject. Hemosure are proud to manufacture and sell the fastest growing Immunological Faecal Immunochemical Test (FIT) and have established its place as an industry leader.

 

Contact us if you would like further information on Hemosure or view more of our Clinical Diagnostics range.

IQ Products

Sepsis and Inflammation Detection

IQ Products is a global developer, manufacturer and supplier of a range of high quality antibody-based diagnostic products.

Read More

IQ Products is a global developer, manufacturer and supplier of a range of high quality antibody-based diagnostic products.

 

IQ Products offers different diagnostic tools for the detection and monitoring of sepsis and inflammation using both flow cytometry or ELISA platforms. Use these kits for the quantification of CD163 in serum and plasma.

 

Contact us if you would like further information on IQ Products Sepsis and Inflammation Detection or view more of our Clinical Diagnostics range.

Millipore

Blood Typing Reagents

Millipore’s blood typing reagents are made from human or murine monoclonal antibodies and are formulated in low-protein diluents. These monoclonal reagents offer many advantages over polyclonal-based products.

Read More

Millipore’s blood typing reagents are made from human or murine monoclonal antibodies and are formulated in low-protein diluents. These monoclonal reagents offer many advantages over polyclonal-based products. These advantages include:

 

  • Highly specific – no risk of contaminating antibodies
  • Lot-to-lot consistency
  • Low biohazard risk
  • IgM antibodies allow direct agglutination, react without the need for an indirect antiglobulin test, and can be used to type cells with a positive direct antiglobulin test.

Millipore offer a wide range of monoclonal blood typing finished reagents compliant with the requirements of the European Directive 98/79/EC. The BIOSCOT® portfolio is supplied in a variety of commercial configurations: finished reagent bulk, unlabeled vials, or private trade dress.

 

Contact us if you would like further information on Millipore or view more of our Clinical Diagnostics range.

R&D Systems

Haematology Controls

R&D Systems, a Minnesota-based biological products company, started by producing haematology controls and calibrators for use in hospitals and clinics.

Read More

R&D Systems, a Minnesota-based biological products company, started by producing haematology controls and calibrators for use in hospitals and clinics. In 1977, they introduced their first product, a platelet-rich-plasma control, and in 1981, they became the second manufacturer in the world to release a whole blood control with platelets. Over the years, R&D Systems Haematology has continued to develop a variety of haematology controls. These products continue to be available through the Clinical Controls Division.

 

Contact us if you would like further information on R&D Systems or view more of our Clinical Diagnostics range.

Seegene

Multiplex Molecular Diagnostics

Seegene is a global leader in multiplex molecular diagnostics. Their molecular platforms provide simultaneous and multiple detection technologies, which are unique and have already surpassed the limits of conventional diagnostic techniques and provided a means of testing dozens of pathogens at once.

Read More

Seegene is a global leader in multiplex molecular diagnostics. Their molecular platforms provide simultaneous and multiple detection technologies, which are unique and have already surpassed the limits of conventional diagnostic techniques and provided a means of testing dozens of pathogens at once.

 

As more diseases are discovered around the world, Seegene is taking the lead in developing new technology for accurate diagnosis. They aim to create more opportunities for patients to start a new chapter of their lives by experiencing innovative technologies-based products to increase chances for their successful treatments. Seegene endlessly strives toward the new possibility of a world free of disease.

 

Seegene’s simultaneous and multiple detection technologies, which are unique and superior, have already surpassed the limits of conventional diagnostic techniques and provided a means of testing dozens of pathogens at once.

 

Contact us if you would like further information on Seegene Multiplex Molecular Diagnostics or view more of our Clinical Diagnostics or Life Sciences range.

Information

Feel free to contact us

    Our offices

    Zurich

    Our Offices

    Ireland

    Unit C3, M7 Business Park, Newhall, Naas, Co Kildare, W91 XF79, Ireland,